Your browser doesn't support javascript.
loading
Drug-Drug Interaction between the Direct-Acting Antiviral Regimen of Ombitasvir-Paritaprevir-Ritonavir plus Dasabuvir and the HIV Antiretroviral Agent Dolutegravir or Abacavir plus Lamivudine.
Khatri, Amit; Trinh, Roger; Zhao, Weihan; Podsadecki, Thomas; Menon, Rajeev.
Affiliation
  • Khatri A; Division of Clinical Pharmacokinetics and Pharmacodynamics, AbbVie Inc., North Chicago, Illinois, USA.
  • Trinh R; Division of Antiviral Development, AbbVie Inc., North Chicago, Illinois, USA.
  • Zhao W; Division of Clinical Pharmacokinetics and Pharmacodynamics, AbbVie Inc., North Chicago, Illinois, USA.
  • Podsadecki T; Division of Antiviral Development, AbbVie Inc., North Chicago, Illinois, USA.
  • Menon R; Division of Clinical Pharmacokinetics and Pharmacodynamics, AbbVie Inc., North Chicago, Illinois, USA rajeev.menon@abbvie.com.
Antimicrob Agents Chemother ; 60(10): 6244-51, 2016 10.
Article in En | MEDLINE | ID: mdl-27503645
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Retroviral Agents / Drug Interactions Type of study: Prognostic_studies Language: En Journal: Antimicrob Agents Chemother Year: 2016 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Retroviral Agents / Drug Interactions Type of study: Prognostic_studies Language: En Journal: Antimicrob Agents Chemother Year: 2016 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos